Therefore, in this work we aimed to evaluate the diagnostic utility of common immunohistochemical markers, including TOX, FOXP3, CD4 and GATA3, used in diagnosing early-stage MF in order to avoid misdiagnosis and thus ensure early proper management. The gene discussed is GATA3; the disease is mycosis fungoides.